Back to
Virtu Financial LLC
XLO
Showing 0 of 2 quarters
Position history for
Virtu Financial LLC's holdings in XILIO THERAPEUTICS INC
No. Virtu Financial exited its XLO (Xilio Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 10,763 shares worth $6,000. Virtu Financial first reported XLO in Q4 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.